INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 141 filers reported holding INTERSECT ENT INC in Q1 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $16,062,000 | +3.5% | 573,452 | +0.9% | 0.00% | 0.0% |
| Q4 2021 | $15,520,000 | +0.7% | 568,314 | +0.3% | 0.00% | 0.0% |
| Q3 2021 | $15,406,000 | +62.6% | 566,426 | +2.2% | 0.00% | +100.0% |
| Q2 2021 | $9,474,000 | -15.4% | 554,403 | +3.3% | 0.00% | -50.0% |
| Q1 2021 | $11,201,000 | -2.1% | 536,467 | +7.3% | 0.00% | 0.0% |
| Q4 2020 | $11,445,000 | +44.6% | 499,788 | +3.0% | 0.00% | 0.0% |
| Q3 2020 | $7,913,000 | +23.7% | 485,175 | +2.7% | 0.00% | +100.0% |
| Q2 2020 | $6,398,000 | +20.2% | 472,619 | +5.2% | 0.00% | 0.0% |
| Q1 2020 | $5,324,000 | -74.6% | 449,346 | -46.7% | 0.00% | -50.0% |
| Q4 2019 | $20,990,000 | +198.2% | 843,048 | +103.7% | 0.00% | 0.0% |
| Q3 2019 | $7,040,000 | -22.9% | 413,930 | +3.1% | 0.00% | 0.0% |
| Q2 2019 | $9,135,000 | -23.8% | 401,389 | +7.6% | 0.00% | -33.3% |
| Q1 2019 | $11,994,000 | -37.7% | 373,072 | -45.4% | 0.00% | 0.0% |
| Q4 2018 | $19,250,000 | +114.3% | 683,140 | +118.6% | 0.00% | 0.0% |
| Q3 2018 | $8,983,000 | -17.6% | 312,468 | +7.4% | 0.00% | 0.0% |
| Q2 2018 | $10,897,000 | +3.8% | 290,984 | +8.9% | 0.00% | 0.0% |
| Q1 2018 | $10,503,000 | +26.4% | 267,272 | +4.2% | 0.00% | 0.0% |
| Q4 2017 | $8,309,000 | +9.0% | 256,482 | +4.8% | 0.00% | 0.0% |
| Q3 2017 | $7,624,000 | +14.4% | 244,781 | +2.6% | 0.00% | 0.0% |
| Q2 2017 | $6,665,000 | +65.5% | 238,467 | +1.5% | 0.00% | +50.0% |
| Q1 2017 | $4,028,000 | +47.0% | 234,881 | +3.7% | 0.00% | +100.0% |
| Q4 2016 | $2,740,000 | -16.0% | 226,464 | +9.9% | 0.00% | -50.0% |
| Q3 2016 | $3,262,000 | +77.7% | 205,970 | +45.0% | 0.00% | +100.0% |
| Q2 2016 | $1,836,000 | -25.1% | 142,052 | +10.0% | 0.00% | 0.0% |
| Q1 2016 | $2,452,000 | -6.7% | 129,093 | +10.5% | 0.00% | 0.0% |
| Q4 2015 | $2,629,000 | -2.6% | 116,853 | +1.3% | 0.00% | -50.0% |
| Q3 2015 | $2,700,000 | -14.0% | 115,393 | +5.2% | 0.00% | 0.0% |
| Q2 2015 | $3,140,000 | +231.9% | 109,709 | +199.5% | 0.00% | +100.0% |
| Q1 2015 | $946,000 | +74.5% | 36,635 | +25.2% | 0.00% | – |
| Q4 2014 | $542,000 | +91.5% | 29,272 | +59.9% | 0.00% | – |
| Q3 2014 | $283,000 | – | 18,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |